Frost & Sullivan Podcasts

Topic Discussed : Mergers and acquisiton landscape in the Lifescience Industry Speaker : Khushbu JainKey Takeaways: Pharma companies are seeking radical and immediate growth through M&A. Conversely, we can expect a lower volume of total deals but a higher average deal value Diagnostic and research tools segments on the other hand can extract value from inorganic growth by thinking beyond data curation and more about deriving & utilizing insightsOn that note, I hope you enjoyed this session.Please join us for future podcasts and become a member of our Leadership CouncilEmail us at digital@frost.com. Thank you for your time.Related Keywords: Mergers and Acquisitions in Life Science, mega-mergers, mega-acquisitions, M&A in pharma, M&A in biopharma, M&A in contract research organizations, M&A in contract development and manufacturing organizations, M&A in diagnostics, cell and gene therapy, patient engagement 2.0, patient centricity, connected health, Medication Adherenc